Premium
Autoimmune conditions and primary central nervous system lymphoma risk among older adults
Author(s) -
Mahale Parag,
Herr Megan M.,
Engels Eric A.,
Pfeiffer Ruth M.,
Shiels Meredith S.
Publication year - 2020
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.16222
Subject(s) - primary central nervous system lymphoma , medicine , lymphoma , central nervous system , primary (astronomy) , hodgkin lymphoma , immunology , pediatrics , oncology , physics , astronomy
Summary Primary central nervous system lymphoma (PCNSL) risk is highly increased in immunosuppressed individuals, such as those with human immunodeficiency virus infection and solid organ transplant recipients, but rates are increasing among immunocompetent older adults (age ≥65 years). We utilized data from a large, nationally‐representative cohort of older adults in the United States and found that PCNSL is significantly associated with systemic lupus erythematosus, polyarteritis nodusa, autoimmune hepatitis, myasthenia gravis and uveitis. Immunosuppressive drugs given to treat these conditions may increase PCNSL risk, but these associations cannot explain the observed temporal increase in PCNSL rates, given the low prevalence of these conditions.